Acrivon Therapeutics
Biotechnology, 480 Arsenal Way Ste 100, Cambridge, Massachusetts, 02472, United States, 11-50 Employees
Who is ACRIVON THERAPEUTICS
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across ...
Read More
-
Headquarters: 480 Arsenal Way Ste 100, Cambridge, Massachusetts, 02472, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2837
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ACRIVON THERAPEUTICS
Acrivon Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Acrivon Therapeutics
Answer: Acrivon Therapeutics's headquarters are located at 480 Arsenal Way Ste 100, Cambridge, Massachusetts, 02472, United States
Answer: Acrivon Therapeutics's official website is https://acrivon.com
Answer: Acrivon Therapeutics's revenue is $10 Million to $25 Million
Answer: Acrivon Therapeutics's SIC: 2837
Answer: Acrivon Therapeutics's NAICS: 325412
Answer: Acrivon Therapeutics has 11-50 employees
Answer: Acrivon Therapeutics is in Biotechnology
Answer: Acrivon Therapeutics contact info: Phone number: Website: https://acrivon.com
Answer: Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month